Bevacizumab dosing every 2 weeks for neovascular age-related macular degeneration refractory to monthly dosing
Mimouni, Michael, Meshi, Amit, Vainer, Igor, Gershoni, Assaf, Koren, Tal, Geffen, Noa, Nemet, Arie Y, Segal, OriLanguage:
english
Journal:
Japanese Journal of Ophthalmology
DOI:
10.1007/s10384-018-0619-0
Date:
September, 2018
File:
PDF, 628 KB
english, 2018